title: Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides.
abstract: Ubiquitin-derived peptides are bactericidal in vitro and contribute to the mycobactericidal activity of the lysosome. To further define interactions of ubiquitin-derived peptides with mycobacteria, we screened for mutants with increased resistance to the bactericidal activity of the synthetic ubiquitin-derived peptide Ub2. The four Ub2-resistant Mycobacterium smegmatis mutants were also resistant to the bactericidal action of other antimicrobial peptides and macrophages. Two mutants were in the mspA gene encoding the main M. smegmatis porin. Using a translocation-deficient MspA point mutant, we showed that susceptibility of M. smegmatis to Ub2 was independent of MspA channel activity. Instead, the M. smegmatis Ub2-resistant mutants shared a common phenotype of decreased cell wall permeability compared with wild-type bacteria. Expression of mspA rendered Mycobacterium tuberculosis CDC1551 more susceptible both to ubiquitin-derived peptides in vitro and to lysosomal killing in macrophages. Finally, biochemical assays designed to assess membrane integrity indicated that Ub2 treatment impairs membrane function of M. smegmatis and M. tuberculosis cells. The M. smegmatis Ub2-resistant mutants were more resistant than wild-type M. smegmatis to this damage. We conclude that Ub2 targets mycobacterial membranes and that reduced membrane permeability provides mycobacteria intrinsic resistance against antimicrobial compounds including bactericidal ubiquitin-derived peptides.
authors.affiliation: Department of Microbiology and Immunology, Cornell University, College of Veterinary Medicine, Ithaca, NY 14853, USA. purdyg@ohsu.edu
authors.forename: Georgiana E
authors.initials: GE
authors.lastname: Purdy
authors.forename: Michael
authors.initials: M
authors.lastname: Niederweis
authors.forename: David G
authors.initials: DG
authors.lastname: Russell
mesh_terms: D000995:Antitubercular Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D002462:Cell Membrane / Q000502:physiology*; D004252:DNA Mutational Analysis; D024881:Drug Resistance, Bacterial; D008264:Macrophages / Q000382:microbiology; D050296:Microbial Viability; D020125:Mutation, Missense; D020102:Mycobacterium smegmatis / Q000187:drug effects*; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics; D010455:Peptides / Q000493:pharmacokinetics / Q000494:pharmacology*; D010539:Permeability; D018272:Porins / Q000235:genetics; D025801:Ubiquitin / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D000995:Antitubercular Agents; D010455:Peptides; D018272:Porins; D025801:Ubiquitin; C121838:mspA protein, Mycobacterium smegmatis
references.citation: J Bacteriol. 2009 Jan;191(2):625-31
references.pmid: 19011036
references.citation: Curr Opin Immunol. 2002 Feb;14(1):96-102
references.pmid: 11790538
references.citation: Microbiology (Reading). 2008 Mar;154(Pt 3):679-692
references.pmid: 18310015
references.citation: Infect Immun. 2000 May;68(5):2671-84
references.pmid: 10768959
references.citation: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6121-6
references.pmid: 12724526
references.citation: Cell. 2004 Dec 17;119(6):753-66
references.pmid: 15607973
references.citation: PLoS Pathog. 2005 Sep;1(1):e2
references.pmid: 16201014
references.citation: J Exp Med. 1992 Apr 1;175(4):1111-22
references.pmid: 1552282
references.citation: Nat Rev Microbiol. 2005 Mar;3(3):238-50
references.pmid: 15703760
references.citation: J Immunol. 2007 Jun 1;178(11):7190-8
references.pmid: 17513768
references.citation: Microbes Infect. 2009 Sep;11(10-11):868-75
references.pmid: 19460455
references.citation: FEMS Microbiol Lett. 1998 Jan 1;158(1):75-81
references.pmid: 9453159
references.citation: Cell Microbiol. 2008 Feb;10(2):529-48
references.pmid: 17986264
references.citation: Mol Microbiol. 2003 Sep;49(5):1167-77
references.pmid: 12940978
references.citation: Mol Microbiol. 1995 Jun;16(5):991-1000
references.pmid: 7476195
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6031-6
references.pmid: 17389386
references.citation: J Immunol. 1998 Feb 1;160(3):1290-6
references.pmid: 9570546
references.citation: J Biol Chem. 1997 May 16;272(20):13326-31
references.pmid: 9148954
references.citation: Cell Microbiol. 2006 Feb;8(2):242-56
references.pmid: 16441435
references.citation: Int J Med Microbiol. 2004 Oct;294(4):235-45
references.pmid: 15532981
references.citation: Antimicrob Agents Chemother. 2004 Nov;48(11):4163-70
references.pmid: 15504836
references.citation: Proc Natl Acad Sci U S A. 1997 May 13;94(10):5243-8
references.pmid: 9144222
references.citation: Antimicrob Agents Chemother. 2008 Jul;52(7):2503-11
references.pmid: 18458127
references.citation: Microbiology (Reading). 2004 Apr;150(Pt 4):853-864
references.pmid: 15073295
references.citation: J Exp Med. 1996 Oct 1;184(4):1349-55
references.pmid: 8879207
references.citation: J Immunol. 2004 Mar 1;172(5):3070-7
references.pmid: 14978112
references.citation: J Cell Sci. 1998 Apr;111 ( Pt 7):897-905
references.pmid: 9490634
references.citation: Cell Host Microbe. 2007 Nov 15;2(5):352-64
references.pmid: 18005756
references.citation: Mol Microbiol. 2001 Apr;40(2):451-64
references.pmid: 11309127
references.citation: Science. 1994 Feb 4;263(5147):678-81
references.pmid: 8303277
references.citation: Microbiology (Reading). 2005 Jul;151(Pt 7):2403-2410
references.pmid: 16000730
references.citation: Biochem J. 1999 Dec 15;344 Pt 3:845-9
references.pmid: 10585872
references.citation: Trends Microbiol. 2001 May;9(5):237-41
references.pmid: 11336841
references.citation: Immunity. 2007 Jul;27(1):11-21
references.pmid: 17663981
references.citation: Infect Immun. 2003 Feb;71(2):922-9
references.pmid: 12540574
references.citation: J Leukoc Biol. 2007 Oct;82(4):934-45
references.pmid: 17609338
references.citation: Nature. 2002 Jan 24;415(6870):389-95
references.pmid: 11807545
references.citation: Nature. 2001 Nov 22;414(6862):454-7
references.pmid: 11719807
references.citation: J Biol Chem. 2004 May 14;279(20):21257-65
references.pmid: 15001577
references.citation: Infect Immun. 2005 Jun;73(6):3492-501
references.pmid: 15908378
references.citation: Tuber Lung Dis. 1997;78(5-6):237-46
references.pmid: 10209678
references.citation: Antimicrob Agents Chemother. 2008 Sep;52(9):3127-34
references.pmid: 18559650
references.citation: Mol Microbiol. 2005 Nov;58(3):714-30
references.pmid: 16238622